Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surfactant therapy.

B Lachmann1

  • 1Department of Anesthesiology, Erasmus University Rotterdam, The Netherlands.

Resuscitation
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Surfactant replacement therapy improved lung function in animal models and a human patient with respiratory failure. This suggests its potential as a treatment for acute respiratory distress syndrome (ARDS).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complement activation contributes to ventilator-induced lung injury in rats.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2017
Same author

Charge heterogeneity study of a Fc-fusion protein, abatacept, using two-dimensional gel electrophoresis.

Die Pharmazie·2015
Same author

Determination of acarbose by capillary zone electrophoresis.

Die Pharmazie·2013
Same author

Lactic acid oligomers (OLAs) as prodrug moieties.

Die Pharmazie·2013
Same author

Evaluation of a short stability-indicating HPLC method for diclofenac sodium gels.

Die Pharmazie·2013
Same author

Blood-brain barrier in vitro models as tools in drug discovery: assessment of the transport ranking of antihistaminic drugs.

Die Pharmazie·2012
Same journal

Volume-controlled mechanical ventilation during cardiopulmonary resuscitation: A systematic review and meta-analysis.

Resuscitation·2026
Same journal

Number of community first responders needed for quick response times to cardiac arrest: a nationwide study.

Resuscitation·2026
Same journal

Device damage and malfunction during dual defibrillation or dual electrical cardioversion: a scoping review.

Resuscitation·2026
Same journal

Pre-hospital neurological risk stratification at return of spontaneous circulation (ROSC) after out-of-hospital cardiac arrest - the Pre-MIRACLE<sub>2</sub> score.

Resuscitation·2026
Same journal

Beyond Creatinine: Kidney Biomarkers as Windows into Ischemia-Reperfusion Injury After Cardiac Arrest.

Resuscitation·2026
Same journal

Optimal Site of Tactile Stimulation during Initial Steps of Neonatal Resuscitation: A Three-Arm Randomized Controlled Trial.

Resuscitation·2026
See all related articles

Area of Science:

  • Pulmonary Medicine
  • Critical Care Medicine
  • Biomedical Engineering

Background:

  • Respiratory failure can be induced by various insults to lung surfactant.
  • Surfactant plays a crucial role in maintaining lung function and gas exchange.
  • Acute Respiratory Distress Syndrome (ARDS) is a severe form of lung failure.

Purpose of the Study:

  • To present the rationale for surfactant replacement therapy.
  • To evaluate the efficacy of surfactant instillation in animal models of respiratory failure.
  • To assess the potential of surfactant therapy in human patients with severe respiratory failure.

Main Methods:

  • Induction of respiratory failure in 6 animal models using diverse methods (e.g., lung lavage, oxygen radicals, viral infection, anti-lung serum).

Related Experiment Videos

  • Administration of surfactant via instillation in animal models.
  • Clinical trial involving a single patient with severe respiratory failure.

    • Main Results:

    • Surfactant instillation consistently improved gas exchange and lung mechanics in all 6 animal models.
    • Surfactant instillation demonstrated improvement in lung function in the clinical trial patient.
    • The findings support the therapeutic potential of surfactant replacement.

    Conclusions:

    • Surfactant replacement therapy shows promise for treating lung failure.
    • Further investigation is warranted to establish surfactant replacement therapy for ARDS.
    • This therapy could become an acceptable treatment for patients with ARDS.